Research programmes
Research programmes
Research programmes
The MCRC develops a matrix of basic, translational and clinical research programmes that foster multi-disciplinary interactions and collaboration. This will lead to new approaches for therapies, a better understanding of treatment responses and new potential markers of diagnostic and prognostic value.
Basic research feeds into translational programmes and clinical research themes. These can be grouped into three general areas of current and future importance in cancer medicine:
- New therapeutics (including early phase trials of small molecules and cell-based therapies, pharmacology)
- Diagnostics and imaging (such as Positron Emission Tomography [PET], magnetic resonance imaging [MRI], molecular pathology, clinical proteomics – large scale study of proteins and their structure and function, biomarkers and tumour spectroscopy)
- Individualisation of treatment to individual patients (pharmacogenomics – the influence of an individual’s genes on how a drug works – and late effects).
Programmes focusing on specific tumours (such as breast cancer, leukaemia and paediatric cancer), encompassing basic through to clinical activities intersect with these themes. The MCRC will continue to develop programmes on specific tumour types, determined by the recruitment of world-class research leaders. Find out more about our research themes.